GMED(GMED)
GMED
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.20B | $3.39B | $3.60B | $3.94B | $4.33B |
| Low | $3.19B | $3.35B | $3.55B | $3.91B | $4.29B |
| High | $3.21B | $3.42B | $3.65B | $3.98B | $4.37B |
| EBITDA Avg | $788M | $835M | $887M | $970M | $1.07B |
| Low | $786M | $825M | $875M | $962M | $1.06B |
| High | $790M | $843M | $900M | $980M | $1.08B |
| EBIT Avg | $549M | $582M | $618M | $676M | $743M |
| Low | $547M | $575M | $609M | $670M | $737M |
| High | $551M | $587M | $627M | $682M | $750M |
| Net Income Avg | $685M | $740M | $818M | $899M | $1.02B |
| Low | $657M | $657M | $718M | $889M | $1.01B |
| High | $693M | $777M | $924M | $910M | $1.04B |
| EPS Avg | $4.98 | $5.35 | $5.86 | $6.55 | $7.46 |
| Low | $4.79 | $4.79 | $5.23 | $6.48 | $7.38 |
| High | $5.05 | $5.67 | $6.74 | $6.63 | $7.55 |
| Analysts (Rev / EPS) | 11 / 8 | 11 / 8 | 9 / 4 | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $792M | $859M | $800M | $837M | $842M | $914M | $843M | $883M |
| Low | $784M | $846M | $788M | $824M | $829M | $899M | $830M | $869M |
| High | $795M | $872M | $811M | $849M | $854M | $927M | $855M | $895M |
| EBITDA Avg | $195M | $211M | $197M | $206M | $207M | $225M | $208M | $217M |
| Low | $193M | $208M | $194M | $203M | $204M | $222M | $204M | $214M |
| High | $196M | $215M | $200M | $209M | $210M | $228M | $211M | $221M |
| EBIT Avg | $136M | $147M | $137M | $144M | $144M | $157M | $145M | $151M |
| Low | $134M | $145M | $135M | $141M | $142M | $154M | $142M | $149M |
| High | $136M | $150M | $139M | $146M | $147M | $159M | $147M | $154M |
| Net Income Avg | $164M | $185M | $169M | $186M | $183M | $201M | $184M | $192M |
| Low | $160M | $184M | $165M | $182M | $179M | $197M | $181M | $189M |
| High | $167M | $189M | $172M | $190M | $186M | $205M | $188M | $196M |
| EPS Avg | $1.19 | $1.34 | $1.22 | $1.35 | $1.32 | $1.46 | $1.33 | $1.39 |
| Low | $1.16 | $1.33 | $1.20 | $1.32 | $1.30 | $1.43 | $1.31 | $1.36 |
| High | $1.21 | $1.37 | $1.24 | $1.37 | $1.35 | $1.48 | $1.36 | $1.42 |
| Analysts (Rev / EPS) | 9 / 9 | 9 / 8 | 7 / 3 | 4 / 4 | 4 / 3 | 7 / 4 | 7 / 4 | 3 / 5 |